Stocks
Veradermics, IncorporatedMANE
NYSEHealthcareBiotechnology$138.78
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company developing therapies for dermatological conditions, with a focus on treatments for hair loss and other skin disorders. Its lead candidate targets androgenetic alopecia, positioning it in a competitive market with significant unmet need. Investors track the company for its pipeline progress and potential in the dermatology space.
52W Range: $32.00-$141.75
Congressional Interest in Veradermics, Incorporated (MANE)
No congressional trades have been disclosed for Veradermics, Incorporated (MANE) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading MANE?
No congressional trades found for this stock.